First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
23.75
+3.70 (18.45%)
Apr 29, 2026, 2:48 PM EDT - Market open
TRAX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 238.2 | 123.08 | 35.97 |
| Short-Term Investments | 73.44 | 262.29 | 354.94 |
| Cash & Short-Term Investments | 311.64 | 385.37 | 390.9 |
| Cash Growth | -19.13% | -1.42% | - |
| Prepaid Expenses | 4.76 | 4.56 | 7.65 |
| Total Current Assets | 316.4 | 389.93 | 398.56 |
| Property, Plant & Equipment | 13.89 | 16.23 | 18.27 |
| Long-Term Investments | - | 35.47 | 27.03 |
| Other Long-Term Assets | 0.26 | 0.26 | 0.26 |
| Accounts Payable | 3.11 | 3.79 | 2.43 |
| Accrued Expenses | 25.83 | 30.47 | 14.02 |
| Current Portion of Leases | 2.08 | 1.93 | 1.78 |
| Total Current Liabilities | 31.02 | 36.18 | 18.22 |
| Long-Term Leases | 12.03 | 14.11 | 16.04 |
| Common Stock | 287.51 | 391.29 | 410.65 |
| Comprehensive Income & Other | -0.02 | 0.31 | -0.8 |
| Total Liabilities & Equity | 330.55 | 441.89 | 444.11 |
| Total Debt | 14.11 | 16.04 | 17.81 |
| Net Cash (Debt) | 297.53 | 369.34 | 373.09 |
| Net Cash Growth | -19.44% | -1.01% | - |
| Working Capital | 285.38 | 353.75 | 380.33 |
| Tangible Book Value | 287.49 | 391.6 | 409.85 |
| Machinery | 8.31 | 8.25 | 8.11 |
| Leasehold Improvements | 0.2 | 0.2 | 0.2 |
Source: S&P Capital IQ. Standard template.
Financial Sources.